<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(9)</volume><submitter>Tan D</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Safe and effective wound healing can be a major clinical challenge. Inflammation and vascular impairment are two main causes of inadequate wound healing. &lt;b>Methods:&lt;/b> Here, we developed a versatile hydrogel wound dressing, comprising a straightforward physical mixture of royal jelly-derived extracellular vesicles (RJ-EVs) and methacrylic anhydride modified sericin (SerMA), to accelerate wound healing by inhibiting inflammation and promoting vascular reparation. &lt;b>Results:&lt;/b> The RJ-EVs showed satisfactory anti-inflammatory and antioxidant effects, and significantly promoted L929 cell proliferation and migration &lt;i>in vitro&lt;/i>. Meanwhile, the photocrosslinked SerMA hydrogel with its porous interior structure and high fluidity made it a good candidate for wound dressing. The RJ-EVs can be gradually released from the SerMA hydrogel at the wound site, ensuring the restorative effect of RJ-EVs. In a full-thickness skin defect model, the SerMA/RJ-EVs hydrogel dressing accelerated wound healing with a healing rate of 96.8% by improving cell proliferation and angiogenesis. The RNA sequencing results further revealed that the SerMA/RJ-EVs hydrogel dressing was involved in inflammatory damage repair-related pathways including recombinational repair, epidermis development, and Wnt signaling. &lt;b>Conclusion:&lt;/b> This SerMA/RJ-EVs hydrogel dressing offers a simple, safe and robust strategy for modulating inflammation and vascular impairment for accelerated wound healing.</pubmed_abstract><journal>Theranostics</journal><pagination>2811-2824</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10240823</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>In situ&lt;/i> formed scaffold with royal jelly-derived extracellular vesicles for wound healing.</pubmed_title><pmcid>PMC10240823</pmcid><pubmed_authors>Pan Y</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Tan D</pubmed_authors><pubmed_authors>Zhu W</pubmed_authors><pubmed_authors>Huang Q</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Rao L</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>In situ&lt;/i> formed scaffold with royal jelly-derived extracellular vesicles for wound healing.</name><description>&lt;b>Background:&lt;/b> Safe and effective wound healing can be a major clinical challenge. Inflammation and vascular impairment are two main causes of inadequate wound healing. &lt;b>Methods:&lt;/b> Here, we developed a versatile hydrogel wound dressing, comprising a straightforward physical mixture of royal jelly-derived extracellular vesicles (RJ-EVs) and methacrylic anhydride modified sericin (SerMA), to accelerate wound healing by inhibiting inflammation and promoting vascular reparation. &lt;b>Results:&lt;/b> The RJ-EVs showed satisfactory anti-inflammatory and antioxidant effects, and significantly promoted L929 cell proliferation and migration &lt;i>in vitro&lt;/i>. Meanwhile, the photocrosslinked SerMA hydrogel with its porous interior structure and high fluidity made it a good candidate for wound dressing. The RJ-EVs can be gradually released from the SerMA hydrogel at the wound site, ensuring the restorative effect of RJ-EVs. In a full-thickness skin defect model, the SerMA/RJ-EVs hydrogel dressing accelerated wound healing with a healing rate of 96.8% by improving cell proliferation and angiogenesis. The RNA sequencing results further revealed that the SerMA/RJ-EVs hydrogel dressing was involved in inflammatory damage repair-related pathways including recombinational repair, epidermis development, and Wnt signaling. &lt;b>Conclusion:&lt;/b> This SerMA/RJ-EVs hydrogel dressing offers a simple, safe and robust strategy for modulating inflammation and vascular impairment for accelerated wound healing.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-04T07:59:30.287Z</modification><creation>2025-04-04T07:59:30.287Z</creation></dates><accession>S-EPMC10240823</accession><cross_references><pubmed>37284440</pubmed><doi>10.7150/thno.84665</doi></cross_references></HashMap>